News

For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of ...
Scientists David Baker's UW lab are using generative AI to target 'undruggable' proteins for creating new drugs and ...
With ingredient transparency, stack-friendly simplicity, and daily-use reliability, GenuinePurity is quickly becoming the ...
(NOTE: This article was originally published in the India Today issue dated July 14, 2025) ...
In a world where heart disease continues to rank as the top cause of death, scientists are urgently searching for ways to prevent it—especially among people facing obesity. Now, new research points to ...
Discover how Adipotide, a promising peptide, could revolutionise our understanding of adipose tissue dynamics and metabolic regulation, paving the way for innovative therapies.
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.
For example, they found that when an insulin receptor experiences decreased mobility, it acts less efficiently on IRS1, a molecule to which it usually adds a phosphate group.
Faster, More Confident Small Molecule Structure Verification in Pharmaceutical R&D Explore how ASV transforms structure verification into a scalable, consistent and reliable process.
NR: Most studies use 250–500 mg per day. This range has been shown to safely raise NAD+ levels in humans. NMN: Common doses ...